Opening book details…
About this nonfiction
Ki67, Chemotherapy Response, and Prognosis in Breast Cancer Patients Receiving Neoadjuvant Treatment by Peter A Fasching, Katharina Heusinger, Lothar Haeberle, Melitta Niklos, Alexander Hein, Christian M Bayer, Claudia Rauh, Ruediger Schulz-Wendtland, Mayada R Bani, Michael Schrauder, Laura Kahmann, Michael P Lux, Johanna D Strehl, Arndt Hartmann, Arno Dimmler, Matthias W Beckmann, David L Wachter is a nonfiction available to read on EtoBox.
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Peter A Fasching, Katharina Heusinger, Lothar Haeberle, Melitta Niklos, Alexander Hein, Christian M Bayer, Claudia Rauh, Ruediger Schulz-Wendtland, Mayada R Bani, Michael Schrauder, Laura Kahmann, Michael P Lux, Johanna D Strehl, Arndt Hartmann, Arno Dimmler, Matthias W Beckmann, David L Wachter
- Publisher
- BioMed Central
- Published
- 2011
- Language
- EN
- Category
- nonfiction
More by Peter A Fasching, Katharina Heusinger, Lothar Haeberle, Melitta Niklos, Alexander Hein, Christian M Bayer, Claudia Rauh, Ruediger Schulz-Wendtland, Mayada R Bani, Michael Schrauder, Laura Kahmann, Michael P Lux, Johanna D Strehl, Arndt Hartmann, Arno Dimmler, Matthias W Beckmann, David L Wachter
Similar books
- Prediction of Pathological Complete Response and Prognosis in Patients with Neoadjuvant Treatment for Triple-negative Breast Cancer — Paul Gass, Michael P. Lux, Claudia Rauh, Alexander Hein, Mayada R. Bani, Cornelia Fiessler, Arndt Hartmann, Lothar Häberle, Jutta Pretscher, Ramona Erber, David L. Wachter, Rüdiger Schulz-Wendtland, Matthias W. Beckmann, Peter A. Fasching, Marius Wunderle (2018)
- Breast Cancer : Prognosis, Treatment, and Prevention — Jorge R Pasqualini; Library of Congress Science, Technology, and Business Division Science Reference Services (2002)
- Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy — Hadalin, Vlasta; Pislar, Nina; Borstnar, Simona; Matos, Erika; Kovac, Anja; Dobovisek, Luka; Cankar, Kaja; Perhavec, Andraz (2022)
- HER2 and ESR1 mRNA Expression Levels and Response to Neoadjuvant Trastuzumab Plus Chemotherapy in Patients with Primary Breast Cancer — Carsten Denkert, Jens Huober, Sibylle Loibl, Judith Prinzler, Ralf Kronenwett, Silvia Darb-Esfahani, Jan C. Brase, Christine Solbach, Keyur Mehta, Peter A. Fasching, Bruno V Sinn, Knut Engels, Mattea Reinisch, Martin-Leo Hansmann, Hans Tesch, Gunter von Minckwitz, Michael Untch (2013)
- Neoadjuvant Treatment of Breast Cancer – Advances and Limitations — Peter A. Fasching, Paul Gaß, Alexander Hein (2016)
- MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients — Hanna Huebner, Lothar Häberle, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Visnja Fink, Fabienne Schochter, Inga Bekes, Sven Mahner, Julia Jückstock, Naiba Nabieva, Andreas Schneeweiss, Hans Tesch, Sara V. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Mahdi Rezai, Matthias W. Beckmann, Peter A. Fasching, Wolfgang Janni, Brigitte Rack (2022)